Home Tags CHAPTER 11 WEEKLY FILINGS

Tag: CHAPTER 11 WEEKLY FILINGS

Recent Articles

AVIVA To Invest $66 Million In Sustainable VC

AVIVA plc. has announced to invest close to $66 million in sustainable venture capital. Thereby, the company’s first commitment was to make...

Cove.tool Raises $30 Million, With RDJ And Coatue

Cove.tool, also known as Covetool Inc, raised $30 million in a recent Series B funding round. Robert Downey Junior (RDJ), and Coatue...
Southampton FC

Serbian Media Baron Acquires Southampton FC For $136 Million

Dragan Šolak, the founder of Serbian mass media company United Group, has acquired 80% of stake of Southampton FC last week. The...

Sri Lanka On The Brink Of Bankruptcy As Inflation Hits Record High Levels

The COVID-19 pandemic has left Sri Lanka on the edge of bankruptcy as it nears a possible economic collapse. The country is...

GameStop Plans To Enter The World Of Cryptocurrency

The share price of GameStop rose as it plans to create a marketplace for non-fungible tokens (NFTs). The company plans to enter...

Most Popular

ECB President Christine Lagarde

ECB President Lagarde Expects Strong Rebound for EU Economy in Second Half

Despite COVID-19 struggles, European Central Bank (ECB) President Christine Lagarde told CNBC on April 9 that the European Union (EU) will hit...

New High Yield Bond Ratings January 25 – January 29, 2021

At least three companies received revisions on high yield bond ratings during the week of January 25 - January 29, 2021. These...

LA Dodgers Owner Files for IPO Through SPAC

LA Dodgers owner, Todd Boehly, has filed a $500 million IPO through a third SPAC. The SPAC, Horizon Acquisition Corp III, is...

Dr. John McHutchison as the Global Impact Award 2020 winner

John McHutchison of Assembly Biosciences, Inc. is a familiar name if you’ve heard about the recent advancements in the treatment of chronic hepatitis. The company has done a great deal to develop unique and much-needed therapeutics targeting diseases related to the microbiome.

ESCAPE Bio Closes $73 Million in Financing

Clinical stage company, ESCAPE Bio, recently announced the closing of $73 million in financing. The San Francisco-based company develops treatments for neurodegenerative...